NasdaqGM:STAAMedical Equipment
Can STAAR Surgical (STAA) Justify Its Valuation As Sales Guidance Tops $90 Million?
STAAR Surgical (STAA) guided second quarter 2026 net sales to more than $90 million, compared with $44.3 million a year earlier. This update immediately puts revenue momentum at the center of the investment debate.
See our latest analysis for STAAR Surgical.
The latest guidance lands against a mixed trading backdrop for STAAR Surgical, with the share price down 20.18% over the past month and 12.43% over the past quarter. The 1 year total shareholder return is 21.45%, but the 5 year total...